Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -14.6% | +35.8% | 1 / 3 | +26.8% | -4.23 pp | -9.42 pp | +8.0% | 0.05 | 36.74 | 248 | +26,8% | 55,6 | −10,7% | 36.74 | 20.68 | +77,7% |
| Pts | 0 | 8 | 4 | 12 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 57.800 (close price on 2026-10-19)EPS (TTM): 1.573
Financial charts
1.Revenue & growth
VND bn248Q2/26
1.Revenue & growth
VND bn248Q2/26
2.Profit & growth
VND bn45,0Q2/26
3.Profit mix (Penman)
VND bn231Q2/26
4.Margins & cost structure
%17.9%Q2/26
5.Returns & cash cycle
% · days1.6%Q2/26
6.Earnings quality & cash
VND bn21,8Q2/26
7.Asset structure
VND bn2.905Q2/26
8.Funding & debt health
VND bn · times2.905Q2/26
9.Revenue backlog
VND bn10,3Q2/26
10.Valuation
times · %37,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %360Q2/26
Adjusted EPS growth, latest quarter
-22.8%
Average adjusted EPS growth, 3 quarters
33.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26